BiotechTube

HTX-011 + Bupivacaine Hydrochloride + Ibuprofen + Acetaminophen

ApprovedCompleted
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Postoperative Pain

Conditions

Postoperative Pain, Total Shoulder Arthroplasty, Multimodal Analgesia

Trial Timeline

Oct 20, 2021 → Jul 29, 2022

NCT ID
NCT06109415

About HTX-011 + Bupivacaine Hydrochloride + Ibuprofen + Acetaminophen

HTX-011 + Bupivacaine Hydrochloride + Ibuprofen + Acetaminophen is a approved stage product being developed by Heron Therapeutics for Postoperative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT06109415. Target conditions include Postoperative Pain, Total Shoulder Arthroplasty, Multimodal Analgesia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT06109415ApprovedCompleted
NCT06109428ApprovedCompleted

Competing Products

20 competing products in Postoperative Pain

See all competitors
ProductCompanyStageHype Score
Naldemedine + PlaceboShionogiPhase 2
52
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVEisaiApproved
85
Lemborexant 5 mg + Control (placebo) groupEisaiPhase 2
52
Ondansetron + PalonosetronEisaiPhase 2
52
AQUAVAN (fospropofol disodium; GPI 15715 )EisaiPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2/3
65
Levofloxacin Ophthalmic + CefuroximeSanten PharmaceuticalPhase 1/2
41
Levofloxacin Ophthalmic Product + Moxifloxacin Ophthalmic SolutionSanten PharmaceuticalPhase 1/2
41
Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparationJiangsu Hengrui MedicinePhase 1
33
SHR0410 Injection + SHR0410 Injection + PlaceboJiangsu Hengrui MedicinePhase 3
77
SHR8554 InjectionJiangsu Hengrui MedicinePhase 1
33
EsomeprazoleAstraZenecaApproved
85
deep neuromuscular blockMerckPre-clinical
23
Rolapitant Dose 1 + Rolapitant Dose 2 + Rolapitant Dose 3 + Rolapitant Dose 4 + Ondansetron + PlaceboMerckPhase 2
52
MK0966, rofecoxib + Comparator: valdecoxibMerckPhase 3
77
Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, PlaceboMerckApproved
85
MK0719MerckPhase 2
52
Sugammadex + NeostigmineMerckApproved
85
MK0869, aprepitant + Comparator: ondansetron IVMerckPhase 3
77

Other Products from Heron Therapeutics

SUSTOLApproved
77
HTX-011 + Bupivacaine Hydrochloride + Ibuprofen + AcetaminophenApproved
77
Bupivacaine HClApproved
77
Bupivacaine liposome injectable suspension + Bupivacaine HCl without epinephrine via continuous infusionApproved
77
ZYNRELEF 200Mg-6Mg Extended-Release SolutionApproved
77